Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294408857> ?p ?o ?g. }
- W4294408857 endingPage "456" @default.
- W4294408857 startingPage "441" @default.
- W4294408857 abstract "Background: Cachexia is usually associated with elevated serum interleukin-6 (IL-6) as it stimulates the breakdown of muscle proteins and promotes wasting. Objective: A case-control study to evaluate the relationship between weight loss, facial fat loss, and IL-6 in antiretroviral-naïve and treated participants living with HIV/AIDS. Methods: IL-6 was assayed by High performance liquid chromatography (HPLC) in 97 in consecutive newly diagnosed antiretroviral-naive (ART-naïve) people living with HIV/AIDS (age ≥18 years); and 118 consecutive, age-matched participants currently on Highly Active Antiretroviral Therapy (HAART), using age as a criterion. In the treated group, 78 (66.7%) subjects were on zidovudine, lamivudine with nevirapine (Z+L+N); 27(23.1%) on tenofovir, lamivudine with emtricitabine (T+L+E); 5(4.3%) on zidovudine, lamivudine with emtricitabine (Z+L+E); 4(3.4%) on zidovudine, lamivudine with tenofovir (Z+L+T); 2(1.7%) on lamivudine, tenofovir with nevirapine (L+T+N); 1(0.9%) on tenofovir, zidovudine, emtricitabine (Z+T+E). Results: A total of 215 participants: 97 ART-naive and 118 HAART-treated, age-matched subjects (40.3±9.6 versus 42.7±10.20years, p=0.08). The mean IL-6 was significantly higher in naïve than treated (0.69±0.04 versus 0.66±0.04 pg/ml, p =0.002). In all, 73 subjects experienced weight loss, 56(76.7%) naive, 17(23.3%) treated, p <0.0001, with significantly higher IL-6 in those with weight loss (0.69±0.05 versus 0.67±0.05pg/ml, p= 0.047). Fifty-eight (27.0%) subjects experienced facial fat loss, 49 (84.5%) naïve, and 9 (15.5%) treated, p <0.0001, with significantly higher IL-6 in those with facial fat loss (0.7 ± 0.05 versus 0.67±0.05pg/ml, p= 0.0001). Negative correlation exists between IL-6 and CD4+ count (r=-0.141, p=0.041). In logistic regression, independent predictors of weight loss include: IL-6 (Adjusted Odds Ratio, aOR 1.3, 95%CI 0·1–2·6, p=0.047); HIV duration (aOR 11.6, p <0.0001); AIDS-defining illness (aOR 3.5, p <0.0001); CD4+ count (aOR 3.2, p=0.004); HAART status (aOR 2.7, p<0.0001). Conclusion: HIV infection is associated with elevation of serum interleukin-6, which likely contributes to weight and facial fat loss among the treatment-naïve participants; while HAART is associated with suppressed IL-6 levels, thereby ameliorating weight and facial fat loss. Inverse relationship exists between serum IL-6 and CD4+ count; serum IL-6 could differentiate between mild- to moderate and severe immunosuppressive states." @default.
- W4294408857 created "2022-09-03" @default.
- W4294408857 creator A5018963089 @default.
- W4294408857 creator A5028276774 @default.
- W4294408857 creator A5028400201 @default.
- W4294408857 creator A5034812131 @default.
- W4294408857 creator A5063139698 @default.
- W4294408857 creator A5065126331 @default.
- W4294408857 creator A5066007285 @default.
- W4294408857 creator A5075630093 @default.
- W4294408857 creator A5076162050 @default.
- W4294408857 creator A5084938363 @default.
- W4294408857 date "2022-12-01" @default.
- W4294408857 modified "2023-10-17" @default.
- W4294408857 title "Serum Interleukin-6 and Weight Loss in Antiretroviral-naïve and Antiretroviral-treated Patients with HIV/AIDS: Relationships and Predictors" @default.
- W4294408857 cites W1515033630 @default.
- W4294408857 cites W1517660847 @default.
- W4294408857 cites W1576984763 @default.
- W4294408857 cites W157721590 @default.
- W4294408857 cites W1758976127 @default.
- W4294408857 cites W1933809558 @default.
- W4294408857 cites W1937757791 @default.
- W4294408857 cites W1960162449 @default.
- W4294408857 cites W1968708587 @default.
- W4294408857 cites W1985143680 @default.
- W4294408857 cites W1985953874 @default.
- W4294408857 cites W1987426931 @default.
- W4294408857 cites W1993203791 @default.
- W4294408857 cites W2004738014 @default.
- W4294408857 cites W2006152240 @default.
- W4294408857 cites W2006905904 @default.
- W4294408857 cites W2010095497 @default.
- W4294408857 cites W2013711685 @default.
- W4294408857 cites W2019855715 @default.
- W4294408857 cites W2021529748 @default.
- W4294408857 cites W2026600737 @default.
- W4294408857 cites W2034128667 @default.
- W4294408857 cites W2037355485 @default.
- W4294408857 cites W2040901874 @default.
- W4294408857 cites W2049449655 @default.
- W4294408857 cites W2050125360 @default.
- W4294408857 cites W2051670536 @default.
- W4294408857 cites W2053053081 @default.
- W4294408857 cites W2064316942 @default.
- W4294408857 cites W2076725143 @default.
- W4294408857 cites W2093008889 @default.
- W4294408857 cites W2101344452 @default.
- W4294408857 cites W2108762089 @default.
- W4294408857 cites W2117775197 @default.
- W4294408857 cites W2119813498 @default.
- W4294408857 cites W2127517680 @default.
- W4294408857 cites W2133946149 @default.
- W4294408857 cites W2138652733 @default.
- W4294408857 cites W2140056361 @default.
- W4294408857 cites W2141230205 @default.
- W4294408857 cites W2148750104 @default.
- W4294408857 cites W2153136696 @default.
- W4294408857 cites W2153370925 @default.
- W4294408857 cites W2154037649 @default.
- W4294408857 cites W2163617802 @default.
- W4294408857 cites W2319153630 @default.
- W4294408857 cites W2417497111 @default.
- W4294408857 cites W2529422575 @default.
- W4294408857 cites W2544481597 @default.
- W4294408857 cites W2577057019 @default.
- W4294408857 cites W2778030148 @default.
- W4294408857 cites W2889877784 @default.
- W4294408857 cites W2963733420 @default.
- W4294408857 cites W4240243247 @default.
- W4294408857 cites W46469852 @default.
- W4294408857 doi "https://doi.org/10.2174/1570162x20666220901085926" @default.
- W4294408857 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36056868" @default.
- W4294408857 hasPublicationYear "2022" @default.
- W4294408857 type Work @default.
- W4294408857 citedByCount "2" @default.
- W4294408857 countsByYear W42944088572023 @default.
- W4294408857 crossrefType "journal-article" @default.
- W4294408857 hasAuthorship W4294408857A5018963089 @default.
- W4294408857 hasAuthorship W4294408857A5028276774 @default.
- W4294408857 hasAuthorship W4294408857A5028400201 @default.
- W4294408857 hasAuthorship W4294408857A5034812131 @default.
- W4294408857 hasAuthorship W4294408857A5063139698 @default.
- W4294408857 hasAuthorship W4294408857A5065126331 @default.
- W4294408857 hasAuthorship W4294408857A5066007285 @default.
- W4294408857 hasAuthorship W4294408857A5075630093 @default.
- W4294408857 hasAuthorship W4294408857A5076162050 @default.
- W4294408857 hasAuthorship W4294408857A5084938363 @default.
- W4294408857 hasConcept C126322002 @default.
- W4294408857 hasConcept C142462285 @default.
- W4294408857 hasConcept C203014093 @default.
- W4294408857 hasConcept C2522874641 @default.
- W4294408857 hasConcept C2777869810 @default.
- W4294408857 hasConcept C2779130552 @default.
- W4294408857 hasConcept C2779764123 @default.
- W4294408857 hasConcept C2779778239 @default.
- W4294408857 hasConcept C2780216070 @default.
- W4294408857 hasConcept C2780593183 @default.
- W4294408857 hasConcept C2780727368 @default.